The trademark application TRANSFORMING PATIENTS' LIVES THROUGH SCIENCE was filed by Bristol-Myers Squibb Company, a U.S. corporation (the "Applicant"). Application refused.
The application was filed in English (French was selected as the second language).
Deletion of the representative of the trademark registration was recorded on January 26, 2021. Appointment and Replacement of representative of the trademark registration was recorded on January 27, 2021. Appointment and Replacement of representative of the trademark registration was recorded on April 5, 2021.
The Refusal with reference B 018255250 was Rejected according to Article 7(1)(b) EUTMR with decision issued on February 7, 2021 by the EUIPO.